In 2022, the radiofrequency ablation system market is anticipated to be worth US$ 3.7 billion in terms of revenue. The market is projected to expand at a CAGR of 12% to reach a market size of US$ 11.49 billion by 2032.
| Attributes | Details |
|---|---|
| Radiofrequency (RF) Ablation System Market CAGR | 12% |
| Radiofrequency (RF) Ablation System Market (2022) | US$ 3.7 Billion |
| Radiofrequency (RF) Ablation System Market (2032) | US$ 11.49 Billion |
Ablation is the process of removal of undesired organs, abnormal growths or harmful substances from the human body. Ablation is the destruction of a nerve conduction pathway by the means of high frequency alternating currents, delivered by a bipolar or unipolar catheters. Radiofrequency (RF) ablation is a non-surgical procedure which utilizes radio waves or electric currents to interfere with the nerve conduction for a period of around six to nine months.
Heat is generated from medium frequency alternating current in the range of 350-500 kHz. During radiofrequency ablation, a guiding needle reaches the desired tissue with the help of image guidance device such as a CT scan. The tip of the needle transmits radiofrequency energy at the tissue site and produces heat. Radiofrequency ablation procedure requires image guidance techniques alongwith an anesthesiologist and cardiology specialist.
Radiofrequency ablation works on the principle of disruption of conduction of nerve signals, specifically the pain conducting nerve signals. The heat generated due to the electric current causes the formation of a scar tissue to block nerve conduction pathway.
The radiofrequency ablation system market is primarily driven by the rising incidences of cardiovascular and chronic illnesses and the inclination for less invasive procedures. In addition, the rise is anticipated to be boosted by an increase in the number of elderly people and increased life expectancy. Elderly individuals are more likely to develop chronic illnesses, which increases the demand for highly effective treatments and, in turn, propels the RF ablation market.
The fact that healthcare expenditure is increasing and the preference for less invasive procedures is rising contributes significantly to the market growth. The growing occurrence of chronic pain conditions, including osteoporosis and arthritis, along with improved healthcare infrastructure, is likely to promote market expansion.
Several clinical studies demonstrate that the use of radiofrequency ablation systems raises the probability of cancer cure by around 40%. Moreover, almost 60% of cancer patients globally get radiotherapy. Thus, as surgical methods gradually shift from traditional to less invasive, radiofrequency ablation is becoming more popular.
Additionally, radiofrequency ablation system adoption is anticipated to increase throughout the forecast period as a result of technical developments in radiofrequency treatments that are strengthening therapeutic efficacy. The market size will also be influenced by the increasing usage of robotic technologies for the expansion of product applications and the integration of cutting-edge technology in ablation devices to provide improved patient safety and procedure efficiency.
Market growth possibilities of RF ablation systems for pain management are enormous in developing countries such as India, China, and Brazil. Growing the economy and improving insurance policies are key contributing elements. Additionally, the growing elderly population in emerging countries is anticipated to present significant prospects for businesses engaged in the RF ablation devices market.
Players in the global radiofrequency ablation system market for pain treatment are likely to attain profit from attractive growth prospects due to the rising demand for less invasive procedures. Owing to characteristics including fewer postoperative problems and side effects, a shorter hospital stay, and little to no discomfort, minimally invasive operations are preferred by patients.
The creation of leading-edge organisms is a top priority for major companies operating in the global radiofrequency ablation system market. As a result, they have been observed expanding their spending on R&D initiatives. Global improvements in RFA of Cardiac Arrhythmia have created new opportunities for market players for procedural safety. The ability of RFA devices to treat arrhythmia with or without the use of fluoroscopy has significantly increased with the introduction of both ICE imaging and EAM methods. As a result, it is predicted that the demand for it will increase exponentially in the future.
Players in the radiofrequency ablation system market are attempting to hold onto their positions by releasing a variety of RF ablation devices that target certain nerves and stop pain signals from reaching the brain. Along with the new tissue engagement viewer, certain companies are also developing high-quality imaging and mapping capabilities for RF ablation. Modern technology is being incorporated by international players into RFA systems, giving electrophysiologists the ability to visualize and evaluate local tissue reactions to RFA.
The global radiofrequency ablation systems market is particularly driven by its feature of specificity. The advantage of radiofrequency ablation over other ablation medical procedures is that it can be conducted without the need for local anesthesia or conscious sedation anesthesia. Also, radiofrequency ablation specifically treats the particular site of the tissue and causes negligible damage to adjacent tissues.
As a result, patients can resume regular activities within a few days. The success rate of radiofrequency ablation is good, around 70% cases were successful in blocking an intended nerve. Some of the complications associated with radiofrequency ablation are abscess, ARDS (Acute Respiratory Distress Syndrome), burning sensation at the treatment site of tissue, delayed hemorrhage into ablated tissue, diarrhea, fever and renal failure, tumor recurrence or seeding in extreme conditions. Such complications could probably hamper growth of the global radiofrequency ablation system market during the forecast period from 2016 to 2026.
Radiofrequency ablation systems are used to treat tachycardia or fibrillation post an unsuccessful treatment with medications. The aim of radiofrequency ablation is to restore the regular rhythm of the heart. Since 2005, radiofrequency ablation systems have popularized in the global ablation technologies market due to the increasing number of medical studies and publications on radiofrequency ablation technology.
Radiofrequency (RF) ablation systems are categorized under the ablation technologies market. Radiofrequency ablation systems are used majorly in the treatment of arrhythmia. As a result, the arrhythmia application segment is expected to hold a major share in the global radiofrequency ablation system market over the forecast period. Increasing usage of radiofrequency ablation devices in ambulatory surgical centres is projected to boost the growth of global radiofrequency ablation devices market through 2026.
Depending on geographic regions, global radiofrequency ablation system market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. According to Centers for Disease Control & Prevention, an estimated 4 Mn people in the U.S. suffer from atrial fibrillation and it is forecast to increase due to the increasing geriatric population.
In the U.S., the revenues generated from the treatment of atrial fibrillation is approximately US$ 6 Bn annually. As a result, the North America radiofrequency ablation system market is forecast to be the dominating region in terms of value through 2026.
Some of the key market players identified in global Radiofrequency (RF) Ablation System market are MEDTRONIC, Boston Scientific Corporation, AngioDynamics, Stryker Corporation, RF Medical Co Ltd, AtriCure, Inc., F Care Systems, F Care Systems, Gynesonics to name a few.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, accessories and applications.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Radiofrequency (RF) Ablation System market is classified on the basis of application, end use, type and geography.
Explore Similar Insights
Radiofrequency (RF) Ablation System Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
